Role of Tobacco-Related Chemical Carcinogens /Oxyradical
烟草相关化学致癌物/氧化自由基的作用
基本信息
- 批准号:6950641
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:adenocarcinoma cancer risk carcinogenesis chemical carcinogen chronic disease /disorder enzyme activity free radical oxygen gene expression genetic susceptibility inflammation lung neoplasms molecular pathology neoplasm /cancer epidemiology neoplasm /cancer genetics nitric oxide nitric oxide synthase oxidative stress p53 gene /protein polymerase chain reaction prostaglandin endoperoxide synthase smoking tobacco ulcerative colitis
项目摘要
Recent expression profile analyses revealed that lung adenocarcinomas can be divided into subgroups with diverse pathological features. Because cellular heterogeneity of tumors can confound these analyses, we used laser capture microdissection and microarray expression analysis to characterize the molecular profiles of lung adenocarcinomas. We found 45 genes delineating smokers and nonsmokers that were located at chromosomal loci frequently altered in non-small cell lung cancers including 3p21.3, and 27 genes which were differentially expressed between survivors and nonsurvivors 5 years after surgery. These results are consistent with the hypothesis that the abnormal expression of genes involved in maintaining the mitotic spindle checkpoint and genomic stability, e.g., hBUB3, hZW10, and APC2, contribute to the molecular pathogenesis and tumor progression of tobacco smoke-induced adenocarcinoma of the lung. We are currently investigating the functional and genomic consequences of dysregulation of hBUB3, hZW10 and APC2.
We also are molecular profiling lung tumors with neuroendocrine differentiation including typical and atypical carcinoids, small cell carcinomas, and a subset of adenocarcinoma. Poor survival gene expression sets have been identified and internally validated by RT-PCR and protein analyses and cross-validated with an additional tumor cohort.
Free radical-induced cellular stress contributes to cancer during chronic inflammation. Because the p53 pathway can be activated by free radicals, we have investigated mechanisms of p53 activation by the free radical, NO?. NO? from donor drugs induced both ataxia-telangiectasia mutated (ATM) and ATR-dependent p53 posttranslational modifications, leading to an increase in p53 dependent transcriptional targets and G2/M cell cycle checkpoint. Such modifications were also identified in cells cocultured with NO?-releasing macrophages. In noncancerous colon tissues from patients with ulcerative colitis (a cancer-prone chronic inflammatory disease), inducible NO? synthase protein levels were positively correlated with p53 serine 15 phosphorylation levels. Immunostaining of HDM-1 and p21WAF1 was consistent with transcriptionally active p53. Our study highlights a pivotal role of NO? in the induction of cellular stress and the activation of a p53 response pathway during chronic inflammation.
Ulcerative colitis (UC) is associated with chromosomal and microsatellite instability. To investigate the mechanism of this instability, we examined paired tissues from noncancerous colons of 30 UC patients to determine the ativity of two base excision repair (BER) enzymes, AAG, the major 3-methyladenine DNA glycosylase (3-MeA) DNA glycosylase and APE1, the major apurinic site (AP) endonuclease, and to determine the prevalence of microsatellite instability (MSI). AAG and APE1 were significantly increased in the UC colon epithelium undergoing elevated inflammation and MSI was positively correlated with their enzymatic activities. These latter results are supported by mechanistic studies with Leona Samson and coworkers using yeast and human cell models, in which, overexpression of the AAG glycosylase and/or AP endonuclease generated frameshift mutations and MSI. Furthermore, we have shown with Varda Rotter and coworkers that increased NO? enhances AAG glycosylase activity in an animal model. Taken together, our results are consistent with the hypothesis that the adaptive-imbalanced increase in AAG and APE1 is a novel mechanism contributing to MSI in patients with UC, and may extend to other diseases of chronic inflammation or those with MSI of unknown etiology.
Animal models are an integral facet of a comprehensive strategy to investigate human carcinogenesis including the role of inflammation and oxidative stress in carcinogenesis. Therefore, we are investigating animal models with single, double, or triple gene knockouts of p53, NOS2, and cyclooxygenase 1 or 2, to conduct translational studies of gene-microenvironment in carcinogenesis. Our initial results indicate that basal levels of NOS2 are protective against spontaneous lymphoma and sarcoma formation in p53 homozygous and heterozygous knockout mice and one mechanism of this protection is the role of NO? in apoptotic and tumor immunity pathways.
Cyclooxygenase-2 (COX-2) is overexpressed in multiple types of human cancer and is considered a molecular target for both cancer preventive and therapeutic agents. We have also discovered that COX2 is regulated by both the WNT and RAS pathways that function in cooperative transcriptional and posttranscriptional mechanisms. Mutations in the adenomatous polyposis coli (APC) gene and K-ras occur in the majority of human colorectal cancers. Loss of functional APC protein activates the WNT signal transduction pathway, allowing the nuclear accumulation of ?-catenin, which then binds to T-cell factor-4 (Tcf-4), causing increased transcriptional activation of downstream target genes. We have investigated the hypothesis that the activation of the WNT pathway regulates COX-2. COX-2 was downregulated after the induction of full-length APC in the HT29-APC cell line. We identified a Tcf-4-binding element (TBE) in the COX-2 promoter that specifically bound to Tcf-4 in an electrophoretic mobility shift assay. COX-2 promoter luciferase activity is downregulated by APC in a promoter-reporter construct containing TBE, but not with mutant TBE. Mutant ?-catenin expression upregulated the COX-2 promoter activity and the endogenous COX-2 mRNA expression in HuH7 cells, hepatocellular carcinoma cell line, which is partially abrogated by cotransfection with a dominant-negative Tcf-4 expression vector. Although ?-catenin alone did not increase COX-2 protein to detectable levels in HuH7 cells, coexpression of both mutant ?-catenin and mutant K-ras increased COX-2 protein expression, which is consistent with the previous reports that K-ras can stabilize COX-2 mRNA. Taken together, our data support the hypothesis that COX-2 is downregulated by APC and upregulated by nuclear ?-catenin accumulation, and additionally implicate the WNT signal transduction pathway in colon and liver carcinogenesis. These data further identify the complex interaction of the NO?, WNT, RAS, and COX2 pathways.
最近的表达谱分析显示,肺腺癌可分为具有不同病理特征的亚群。由于肿瘤的细胞异质性可能会混淆这些分析,我们使用激光捕获显微解剖和微阵列表达分析来表征肺腺癌的分子谱。我们发现了45个描述吸烟者和非吸烟者的基因,这些基因位于非小细胞肺癌中经常改变的染色体位点上,包括3p21.3,以及27个基因在手术后5年的幸存者和非幸存者之间差异表达。这些结果与hBUB3、hZW10和APC2等参与维持有丝分裂纺锤体检查点和基因组稳定性的基因的异常表达参与烟草烟雾诱导的肺腺癌的分子发病和肿瘤进展的假设一致。我们目前正在研究hBUB3, hZW10和APC2失调的功能和基因组后果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CURTIS HARRIS其他文献
CURTIS HARRIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CURTIS HARRIS', 18)}}的其他基金
The Role of Tobacco-Related Chemical Carcinogens and Oxyradicals in Human Cancer
烟草相关化学致癌物和氧化自由基在人类癌症中的作用
- 批准号:
6433193 - 财政年份:
- 资助金额:
-- - 项目类别:
Molecular Epidemiology and Molecular Carcinogenesis of H
H 的分子流行病学和分子致癌作用
- 批准号:
7337863 - 财政年份:
- 资助金额:
-- - 项目类别:
THE ROLE OF TOBACCO-RELATED CHEMICAL CARCINOGENS AND OXYRADICALS IN HUMAN CANCER
烟草相关化学致癌物和氧化自由基在人类癌症中的作用
- 批准号:
6289305 - 财政年份:
- 资助金额:
-- - 项目类别:
Molecular Epidemiology and Molecular Carcinogenesis of H
H 的分子流行病学和分子致癌作用
- 批准号:
7038535 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Urinary Phthalate Biomarker Concentrations and Breast and Prostate Cancer Risk in a National Cohort of Adults in Canada
加拿大全国成人队列中尿液邻苯二甲酸盐生物标志物浓度与乳腺癌和前列腺癌风险
- 批准号:
494953 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
高风险良性乳腺诊断女性的临床乳腺癌风险预测模型
- 批准号:
10719777 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders
深度学习图像分析算法可改善口腔潜在恶性疾病的口腔癌风险评估
- 批准号:
10805177 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Prospective metabolomics investigation of gastric cancer risk in African Americans and European Whites with a low socioeconomic status
社会经济地位较低的非裔美国人和欧洲白人胃癌风险的前瞻性代谢组学调查
- 批准号:
10912190 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Developing diagnostics of patient-specific cancer risk and early-stage tumorigenesis
开发患者特异性癌症风险和早期肿瘤发生的诊断方法
- 批准号:
478999 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Environmental Metal Exposures and Breast Cancer Risk: A Prospective Study of Nationally Representative Canadian Data
环境金属暴露与乳腺癌风险:加拿大全国代表性数据的前瞻性研究
- 批准号:
495159 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Mechanisms of tamoxifen-associated endometrial cancer risk
他莫昔芬相关子宫内膜癌风险的机制
- 批准号:
10650054 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery
影响减肥手术后结直肠癌风险的肠道微生物相关机制
- 批准号:
10733566 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause?
肥胖、身体脂肪分布和乳腺癌风险:内脏脂肪是绝经后的罪魁祸首吗?
- 批准号:
10586626 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Optimization of a personalized skin cancer risk intervention for at-risk young adults
针对高危年轻人的个性化皮肤癌风险干预措施的优化
- 批准号:
10582944 - 财政年份:2023
- 资助金额:
-- - 项目类别: